When it comes to your business, value isn’t just about numbers. It’s about what lies beneath. Managing Director Dave Sheppard speaks to building intrinsic value in your medtech manufacturing business on the Moore on Manufacturing podcast.

The current tariff environment underscores the importance of agility, adaptability, and strategic foresight in maintaining and enhancing competitive leadership.

Learn more about how current trade policies and tariffs on medical devices are shaking up U.S. medical device manufacturing.

Good news drives M&A activity and bad news is tolerable as long as it is understood, but uncertainty is the main nemesis of growth.

Factors contributing to manufacturing’s continuous evolution include reproducible, high-quality, AI-enabled technologies; higher product demand; and cost pressures.

It will be exciting to watch this M&A resurgence continue to take shape through 2025 and beyond.

Whether through mergers and acquisitions or spinoffs, the spine sector looks significantly different than it did in 2020.

Asia has remained an industrial stalwart for its unique combination of cost efficiency, technological expertise, and scalability.

Ten years ago, finding orthopedic companies at CES was quite a surprise. Now, it’s more shocking to discover who’s missing.

When considering a sale of your company, be sure to work with an expert who has been through the process and knows how to prepare.

These are just a few of the AI trends we forecast for 2025. We’re energized and excited to see how improvements and innovations in AI will continue to improve healthcare.

As the backbone of MedTech manufacturing, OEM suppliers continued to grow in 2024.

The orthopedic and spine industries this year underwent rapid consolidation through strategic M&A and partnerships.

In a somewhat unexpected move with positive implications for the MedTech industry, the Federal Reserve (Fed) in September opted for a 0.5% interest rate cut.

Selling your business is usually the penultimate milestone in a business owner’s career. A lot depends on its success, including financial longevity, continued legacy and even personal pride. On this episode, hear Dave discuss common mistakes as well as best practices for avoiding those mistakes.

From our perspective in working with private equity (PE) and strategic companies in 2024, mergers and acquisitions (M&A) continues to be highly active in medtech.